The Website of Mengwei Zang’s Laboratory
AMPK, SREBP, and Lipid Metabolism
Dr. Yu Li’s oral presentations in ADA webcasts (2010) (2011)
AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-induced Insulin Resistance
The Synthetic Polyphenol, S17834, Attenuates Accelerated Aortic Atherosclerosis in Insulin Resistant LDLR-/- mice
Confocal Microscopy Image of Increased Nuclear SREBP-1 (Green) in the Hepatocytes of Insulin Resistant Mice and Eliminated by S17834 Treatment
AMPK Directly Phosphorylates human SREBP-1c at Ser372 in vitro
Phospho-SREBP-1c (Ser372) antibody is available in Cell Signaling Technology (#9874) (http://www.cellsignal.com/products/9874.html)
AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-induced Insulin Resistance
